↓ Skip to main content

MVA E2 Recombinant Vaccine in the Treatment of Human Papillomavirus Infection in Men Presenting Intraurethral Flat Condyloma

Overview of attention for article published in BioDrugs, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

patent
3 patents
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
51 Mendeley
Title
MVA E2 Recombinant Vaccine in the Treatment of Human Papillomavirus Infection in Men Presenting Intraurethral Flat Condyloma
Published in
BioDrugs, August 2012
DOI 10.2165/00063030-200721010-00006
Pubmed ID
Authors

Antonio Albarran y Carvajal, Alfonso de la Garza, Benitez Jose Cecilio Cruz Quiroz, Eduardo Vazquez Zea, Ismael Díaz Estrada, Ernesto Mendez Fuentez, Mario López Contreras, Alejandro Andrade-Manzano, Santiago Padilla, Axel Ramírez Varela, Ricardo Rosales

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Brazil 1 2%
Unknown 49 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 25%
Researcher 11 22%
Student > Postgraduate 4 8%
Student > Ph. D. Student 4 8%
Other 3 6%
Other 12 24%
Unknown 4 8%
Readers by discipline Count As %
Medicine and Dentistry 21 41%
Biochemistry, Genetics and Molecular Biology 7 14%
Agricultural and Biological Sciences 7 14%
Nursing and Health Professions 3 6%
Unspecified 3 6%
Other 4 8%
Unknown 6 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2023.
All research outputs
#3,798,611
of 25,374,647 outputs
Outputs from BioDrugs
#120
of 746 outputs
Outputs of similar age
#24,668
of 174,034 outputs
Outputs of similar age from BioDrugs
#27
of 257 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 746 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,034 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 257 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.